Loading…
DNA Backlog Elimination Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
89pct
161d open
vs 5,680 other HR bills in the 106th — cohort avg 56d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (1)
2000 · mid_year · Health Issues
Telemedicine (HR 312, HR 3240, HR 4771, S 2505); Clinical Laboratory Improvement Amendments of 1999 (HR 528); genetic testing and confidentiality (HR 1507, HR 1941, HR 2404, HR 2455, HR 2470, S 573, S 578, S 881, HR 293, HR 306, HR 2457, S 543, S 1322, HR 2878, HR 4049, HR 4585); forensic pathology (HR 1915, HR 2340, S 1196, HR 2810, HR 3087, HR 3233, HR3375, S 1700, S 1981); bioterrorism; Pap smears (HR4330, HR 4571); Medicare issues pertaining to the laboratory; Allied Health Project Grants program (HR 4577); Medical liability reform (HR2242, HR 4577); graduate medical education (HR 1222, HR 1224, HR 1645, HR 1785, HR 2771, HR 4239, S 210, S541, S 1023, S 1024, S 1025, S 1631, S 2394); Patient access to care (HR 2723, HR 2824, HR 2926, HR 2990, HR 3146, S 6, S 326, HR 4577); Issues pertaining to microbiology, blood, diagnostic immunology, cytology, clinical chemistry, forensic pathology); telemedicine (HR 1344, HR 4771, S 2505); other diagnostic screening tests (HR 1285, HR 2930, S 1641, HR 1861, S 1044); rural health (HR 1344, HR 4677, S 1864, S 2735); patient safety (HR 3672, S 2038, S 2378, S 2738, S 2743); and genetics (HR 293, HR 306, HR 2457, HR 2878, S 543, S 1322).
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $60,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2000 · mid_year · Medical/Disease Research/Clinical Labs
Clinical Laboratory Improvement Amendments of 1999 (HR 528); genetic testing and confidentiality (HR 1507, HR 1941, HR 2404, HR 2455, HR 2470, S 573, S 578, S 881, HR 293, HR 306, HR 2457, S 543, S 1322, HR 2878, HR 4049, HR 4585); forensic pathology (HR 1915, HR 2340, S 1196, HR 2810, HR 3087, HR 3233, HR3375, S 1700, S 1981); bioterrorism; Pap smears (HR4330, HR 4571); Issues pertaining to microbiology, blood, diagnostic immunology, cytology, clinical chemistry, forensic pathology); and other diagnostic screening tests (HR 1285, HR 2930, S 1641, HR 1861, S 1044).
Client expense: $60,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2000 · mid_year · Budget/Appropriations
Medicare issues pertaining to the laboratory (HR 3085, HR 1304, HR 3075, HR 3126, HR 3426, H Con Res 290, S 1582, S 1788); Allied Health Project Grants program; Medical liability reform (HR 2242, HR 4577); Pap smears (HR 976, S 1034, HR 1285, HR 4330, HR 4571); forensic pathology (HR 1915, HR 2340, S 1196, HR 2810, HR 3087, HR 3233, HR 3375, S 1700, S 1981); bioterrorism; competitive bidding (HR 1900); other diagnostic screening tests (HR 1285, HR 2930, S 1641, HR 1861, HR 4386, S 1044)
Client expense: $60,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE